Trials / Conditions / Berger Disease
Berger Disease
5 registered clinical trials studyying Berger Disease — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients Wi NCT07498335 | Novartis Pharmaceuticals | Phase 3 |
| Active Not Recruiting | Monthly Dosing of Atacicept in IgAN NCT07020923 | Vera Therapeutics, Inc. | Phase 2 |
| Enrolling By Invitation | A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept NCT06674577 | Vera Therapeutics, Inc. | Phase 2 |
| Active Not Recruiting | Atacicept in Subjects With IgA Nephropathy NCT04716231 | Vera Therapeutics, Inc. | Phase 3 |
| Terminated | A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) NCT03841448 | Alnylam Pharmaceuticals | Phase 2 |